The emerging role of glycolysis and immune evasion in gastric cancer

作者：Shanshan Zheng, Huai Li, Yaqi Li, Yuxuan Chen, Junyu Shen, Menglin Chen, Cancan Zhang, Jian Wu, Qingmin Sun · 发表于：Cancer Cell International · 年份：2023 · DOI：10.1186/s12935-023-03169-1 · 被引用次数：45 · 研究领域：Cancer, Hypoxia, and Metabolism、Immune cells in cancer、Epigenetics and DNA Methylation

Gastric cancer (GC) is the fifth most common malignancy and the third leading cause of cancer-related deaths worldwide. Similar to other types of tumors, GC cells undergo metabolic reprogramming and switch to a "predominantly glycolytic" metabolic pattern to promote its survival and metastasis, also known as "the Warburg effect", which is characterized by enhanced glucose uptake and lactate production. A large number of studies have shown that targeting cancer cells to enhanced glycolysis is a promising strategy, that can make cancer cells more susceptible to other conventional treatment methods of treatment, including chemotherapy, radiotherapy and immunotherapy, and so on. Therefore, this review summarizes the metabolic characteristics of glycolysis in GC cells and focuses on how abnormal lactate concentration can lead to immunosuppression through its effects on the differentiation, metabolism, and function of infiltrating immune cells, and how targeting this phenomenon may be a potential strategy to improve the therapeutic efficacy of GC.